Bronchiolitis
Conditions
Interventions
Participants will be randomized into 2 arms.
Arm 1 (intervention group) will be given 4mg of montelukast sachets/tabs, starting in the evening of the day of admission and continuing each evening for
Sponsors
Department of Paediatrics
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children between 3 months and 18 months with clinical features which are considered in making a diagnosis of bronchiolitis such as prodromal fever, rhinorrhoea and cough 2. At least 2 of the following signs on admission: chest retractions, tachypnoea, wheezing
Exclusion criteria
Exclusion criteria: 1. Symptoms lasting for more than 5 days before admission 2. Previous history of wheezing 3. Underlying chronic diseases eg. cardiac disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The length of stay in days from admission to discharge. Fitness to discharge will be assessed by Wang clinical severity score, need for nebulization and feeding. [Twice daily until discharge and at the end of 7 days of treatment] | — |
Secondary
| Measure | Time frame |
|---|---|
| Wang clinical severity score evolution [Twice daily until discharge and at the end of 7 days of treatment] Oxygen saturation [Twice daily until discharge and at the end of 7 days of treatment] Pulse rate [Twice daily until discharge and at the end of 7 days of treatment ] Need for ICU care [Twice daily until discharge and at the end of 7 days of treatment ] Need for add on therapy [Twice daily until discharge and at the end of 7 days of treatment ] Readmission rate over the 7 days following discharge [Twice daily until discharge and at the end of 7 days of treatment ] | — |
Countries
Sri Lanka
Contacts
Public ContactDr. Guwani Liyanage
Consultant peadiatrician/ Senior Lecturer
Outcome results
None listed